Report Detail
Global Monogenic Disease Testing Market Growth (Status and Outlook) 2022-2028
- RnM4496096 |
- 01 December, 2022 |
- Global |
- 85 Pages |
- LPI(LP Information) |
- Service & Software
The global market for Monogenic Disease Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Monogenic Disease Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Monogenic Disease Testing players cover Celera Support Services, Abbott, ELITech Group, Auto Genomics and PerkinElmer and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Monogenic Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Monogenic Disease Testing market, with both quantitative and qualitative data, to help readers understand how the Monogenic Disease Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Monogenic Disease Testing market and forecasts the market size by Type (Carrier Testing, Diagnostic Testing and New-Born Screening), by Application (Hospitals, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
Segmentation by application
Hospitals
Clinics
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Celera Support Services
Abbott
ELITech Group
Auto Genomics
PerkinElmer
Bio-Rad Laboratories
Chapter Introduction
Chapter 1: Scope of Monogenic Disease Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Monogenic Disease Testing market size and CAGR, Monogenic Disease Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Monogenic Disease Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Monogenic Disease Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Monogenic Disease Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer and Bio-Rad Laboratories, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Monogenic Disease Testing Market Size 2017-2028
- 2.1.2 Monogenic Disease Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Monogenic Disease Testing Segment by Type
- 2.2.1 Carrier Testing
- 2.2.2 Diagnostic Testing
- 2.2.3 New-Born Screening
- 2.2.4 Predictive and Pre-Symptomatic Testing
- 2.2.5 Prenatal Testing
- 2.3 Monogenic Disease Testing Market Size by Type
- 2.3.1 Monogenic Disease Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Monogenic Disease Testing Market Size Market Share by Type (2017-2022)
- 2.4 Monogenic Disease Testing Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 Monogenic Disease Testing Market Size by Application
- 2.5.1 Monogenic Disease Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Monogenic Disease Testing Market Size Market Share by Application (2017-2022)
3 Monogenic Disease Testing Market Size by Player
- 3.1 Monogenic Disease Testing Market Size Market Share by Players
- 3.1.1 Global Monogenic Disease Testing Revenue by Players (2020-2022)
- 3.1.2 Global Monogenic Disease Testing Revenue Market Share by Players (2020-2022)
- 3.2 Global Monogenic Disease Testing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Monogenic Disease Testing by Regions
- 4.1 Monogenic Disease Testing Market Size by Regions (2017-2022)
- 4.2 Americas Monogenic Disease Testing Market Size Growth (2017-2022)
- 4.3 APAC Monogenic Disease Testing Market Size Growth (2017-2022)
- 4.4 Europe Monogenic Disease Testing Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Monogenic Disease Testing Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Monogenic Disease Testing Market Size by Country (2017-2022)
- 5.2 Americas Monogenic Disease Testing Market Size by Type (2017-2022)
- 5.3 Americas Monogenic Disease Testing Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Monogenic Disease Testing Market Size by Region (2017-2022)
- 6.2 APAC Monogenic Disease Testing Market Size by Type (2017-2022)
- 6.3 APAC Monogenic Disease Testing Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Monogenic Disease Testing by Country (2017-2022)
- 7.2 Europe Monogenic Disease Testing Market Size by Type (2017-2022)
- 7.3 Europe Monogenic Disease Testing Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Monogenic Disease Testing by Region (2017-2022)
- 8.2 Middle East & Africa Monogenic Disease Testing Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Monogenic Disease Testing Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Monogenic Disease Testing Market Forecast
- 10.1 Global Monogenic Disease Testing Forecast by Regions (2023-2028)
- 10.1.1 Global Monogenic Disease Testing Forecast by Regions (2023-2028)
- 10.1.2 Americas Monogenic Disease Testing Forecast
- 10.1.3 APAC Monogenic Disease Testing Forecast
- 10.1.4 Europe Monogenic Disease Testing Forecast
- 10.1.5 Middle East & Africa Monogenic Disease Testing Forecast
- 10.2 Americas Monogenic Disease Testing Forecast by Country (2023-2028)
- 10.2.1 United States Monogenic Disease Testing Market Forecast
- 10.2.2 Canada Monogenic Disease Testing Market Forecast
- 10.2.3 Mexico Monogenic Disease Testing Market Forecast
- 10.2.4 Brazil Monogenic Disease Testing Market Forecast
- 10.3 APAC Monogenic Disease Testing Forecast by Region (2023-2028)
- 10.3.1 China Monogenic Disease Testing Market Forecast
- 10.3.2 Japan Monogenic Disease Testing Market Forecast
- 10.3.3 Korea Monogenic Disease Testing Market Forecast
- 10.3.4 Southeast Asia Monogenic Disease Testing Market Forecast
- 10.3.5 India Monogenic Disease Testing Market Forecast
- 10.3.6 Australia Monogenic Disease Testing Market Forecast
- 10.4 Europe Monogenic Disease Testing Forecast by Country (2023-2028)
- 10.4.1 Germany Monogenic Disease Testing Market Forecast
- 10.4.2 France Monogenic Disease Testing Market Forecast
- 10.4.3 UK Monogenic Disease Testing Market Forecast
- 10.4.4 Italy Monogenic Disease Testing Market Forecast
- 10.4.5 Russia Monogenic Disease Testing Market Forecast
- 10.5 Middle East & Africa Monogenic Disease Testing Forecast by Region (2023-2028)
- 10.5.1 Egypt Monogenic Disease Testing Market Forecast
- 10.5.2 South Africa Monogenic Disease Testing Market Forecast
- 10.5.3 Israel Monogenic Disease Testing Market Forecast
- 10.5.4 Turkey Monogenic Disease Testing Market Forecast
- 10.5.5 GCC Countries Monogenic Disease Testing Market Forecast
- 10.6 Global Monogenic Disease Testing Forecast by Type (2023-2028)
- 10.7 Global Monogenic Disease Testing Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Celera Support Services
- 11.1.1 Celera Support Services Company Information
- 11.1.2 Celera Support Services Monogenic Disease Testing Product Offered
- 11.1.3 Celera Support Services Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Celera Support Services Main Business Overview
- 11.1.5 Celera Support Services Latest Developments
- 11.2 Abbott
- 11.2.1 Abbott Company Information
- 11.2.2 Abbott Monogenic Disease Testing Product Offered
- 11.2.3 Abbott Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Abbott Main Business Overview
- 11.2.5 Abbott Latest Developments
- 11.3 ELITech Group
- 11.3.1 ELITech Group Company Information
- 11.3.2 ELITech Group Monogenic Disease Testing Product Offered
- 11.3.3 ELITech Group Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 ELITech Group Main Business Overview
- 11.3.5 ELITech Group Latest Developments
- 11.4 Auto Genomics
- 11.4.1 Auto Genomics Company Information
- 11.4.2 Auto Genomics Monogenic Disease Testing Product Offered
- 11.4.3 Auto Genomics Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Auto Genomics Main Business Overview
- 11.4.5 Auto Genomics Latest Developments
- 11.5 PerkinElmer
- 11.5.1 PerkinElmer Company Information
- 11.5.2 PerkinElmer Monogenic Disease Testing Product Offered
- 11.5.3 PerkinElmer Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 PerkinElmer Main Business Overview
- 11.5.5 PerkinElmer Latest Developments
- 11.6 Bio-Rad Laboratories
- 11.6.1 Bio-Rad Laboratories Company Information
- 11.6.2 Bio-Rad Laboratories Monogenic Disease Testing Product Offered
- 11.6.3 Bio-Rad Laboratories Monogenic Disease Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Bio-Rad Laboratories Main Business Overview
- 11.6.5 Bio-Rad Laboratories Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Monogenic Disease Testing. Industry analysis & Market Report on Monogenic Disease Testing is a syndicated market report, published as Global Monogenic Disease Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Monogenic Disease Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
